Stephen E. Schachterle1
, George Mtove, Joshua P. Levens, Emily Clemens, Lirong Shi, Amrita Raj, J. Stephen Dumler, Beatriz Munoz, Shelia West, and David J. Sullivan
Figure 4. Effect of azithromycin (AZT) mass drug administration (MDA) in treatment and control villages over space and time, Tanzania, January 12–July 21, 2009AZT MDA control villages (2, 5, 7, and 8) are shown on the left, and AZT MDA treatment villages (1, 3, 4, and 6) are shown on the rightSurvey periods at baseline and month 1 are shown within treatment and control groupsBaseline infection and prevalent infections at month 1 (red circles) and negative tests (white circles) are shownSpatial odds of Plasmodium falciparum (P.f.) infection are shown in areas of high odds of infection (red) and areas of low odds of infection (blue)Ln kernel smoothers were used to show spatial odds.